改写人生：22 年专业照护，KFSHRC 治愈罕见病

Core Viewpoint - King Faisal Specialist Hospital & Research Centre (KFSHRC) successfully performed the world's first liver transplant for a rare genetic coagulation disorder after 22 years of continuous care for the patient since infancy [1][2]. Group 1: Patient Care and Treatment - The patient was diagnosed with congenital plasminogen deficiency, which poses severe threats to tissues and organs due to the absence of a key protein that dissolves blood clots [1]. - The treatment involved regular intravenous infusions of plasminogen and eye drops to alleviate the disease's impact on vision, with annual treatment costs exceeding 6 million Saudi Riyals, fully covered by the Saudi government [2]. - The case required a comprehensive multidisciplinary care system, integrating medical treatment with aspects of life care, including nursing, nutrition, and information technology [1][2]. Group 2: Medical and Institutional Commitment - The successful liver transplant marks a turning point in the patient's condition and offers hope to others facing similar diseases globally [2]. - KFSHRC's vision emphasizes placing patients at the center of care, combining scientific expertise with humanistic care, aligning with its mission to serve society at the highest standards [3].